SCHEMBL22889353

SCHEMBL22889353

c1cc(-c2nc(-c3ccccc3-c3ccc4ccccc4c3)nc(-c3cccc4c3oc3ccccc34)n2)cc(-c2cccc3ccccc23)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.46
GGPS1 O95749 1/20 0.38
ALDH1A1 P00352 4/20 0.38
MAPT P10636 3/20 0.38
PRKDC P78527 3/20 0.38
PIM1 P11309 1/20 0.36
PTGES2 Q9H7Z7 1/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 3/20 0.36
HPGD P15428 2/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
GAA P10253 1/20 0.36
ATM Q13315 2/20 0.35
TP53 P04637 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
MAPK1 P28482 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22889389 0.97 ALOX5 (0.47) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22889232 0.95 ALOX5 (0.46) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22889351 0.95 ALOX5 (0.48) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22888889 0.95 ALOX5 (0.48) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22888921 0.94 ALOX5 (0.45) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22889367 0.94 ALOX5 (0.44) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22889352 0.93 ALOX5 (0.46) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22888635 0.93 ALOX5 (0.43) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22889221 0.93 ALOX5 (0.45) ALOX5GGPS1ALDH1A1MAPTPRKDC
SCHEMBL22889108 0.93 ALOX5 (0.47) ALOX5GGPS1ALDH1A1MAPTPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-11765972-B2 Compound and organic electroluminescence device using the same IDEMITSU KOSAN CO., LTD. (JP) 2023-09-19 US disclosed
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME IDEMITSU KOSAN CO.,LTD. (JP) 2021-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210009527-A1 COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, RPS4Y1, AR ALOX5 3163/4885GGPS1 3177/4885ALDH1A1 1387/4885
US-11765972-B2 Compound and organic electroluminescence device using the same AR, OR10J3, RPS4Y1 ALOX5 3071/4885GGPS1 3231/4885ALDH1A1 1441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.